Number of items: 4.
2022
Bryce, A. S. , Dreyer, S. B., Froeling, F. E.M. and Chang, D. K.
(2022)
Exploring the biology of cancer-associated fibroblasts in pancreatic cancer.
Cancers, 14(21),
5302.
(doi: 10.3390/cancers14215302)
2021
Casolino, R. et al.
(2021)
Homologous recombination deficiency in pancreatic cancer: a systematic review and prevalence meta-analysis.
Journal of Clinical Oncology, 39(23),
pp. 2617-2631.
(doi: 10.1200/JCO.20.03238)
(PMID:34197182)
(PMCID:PMC8331063)
Casolino, R. et al.
(2021)
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine.
Annals of Oncology, 32(2),
pp. 183-196.
(doi: 10.1016/j.annonc.2020.11.013)
(PMID:33248227)
(PMCID:PMC7840891)
Froeling, F. E.M. , Casolino, R., Pea, A., Biankin, A. V. and Chang, D. K.
(2021)
Molecular subtyping and precision medicine for pancreatic cancer.
Journal of Clinical Medicine, 10(1),
149.
(doi: 10.3390/jcm10010149)
(PMID:33406790)
(PMCID:PMC7794969)
This list was generated on Sun Jan 29 05:25:53 2023 GMT.